Acquisition Synergies NTC was acquired by Aldevron, creating an opportunity to cross-sell plasmid DNA manufacturing, non-viral vector design, and technology transfer services to Aldevron’s broader biopharma client base.

Fast DNA Delivery DNA based test articles are delivered in a short turnaround, offering a fast outsourcing option for preclinical programs, CROs, and biotech startups needing rapid prototyping.

Non-viral Focus NTC’s specialization in safe non-viral plasmids and minimal antibiotic-free selection vectors positions it well for gene therapy and DNA vaccine developers prioritizing regulatory simplicity and safety.

Outsourcing & Transfer Cost effective outsourcing of gene design, vector construction, plasmid DNA manufacturing, and technology transfer provides a turnkey option for partners lacking internal capabilities.

Platform Advantage Existing collaborations using the HyperGRO manufacturing platform with Cytovance and licensing with Coridon demonstrate a scalable, platform driven approach to plasmid production and vector design that can be offered to additional CDMOs and biotech developers.